Founders & Retired Partners

C. Richard Kramlich

Chairman & Co-founder

Dick is Co-Founder of NEA and is currently Chairman of the NEA Management Company. He was Managing General Partner of the firm through NEA VII when he turned the reins over to Peter Barris and became a General Partner. During the 20 years Dick was the Managing General Partner of NEA, the partnership achieved top quartile returns for its Limited Partners. Dick began his venture career in 1969 as a General Partner with Arthur Rock and Co. after nine years in general management as Manager of Financial Planning at the Kroger Co. and in investment management as Executive Vice President at Gardner & Preston Moss Company in Boston. In 1977 Dick was an early investor in Apple Computer for his own account. Since co-founding NEA in 1978, he has been involved in ten companies that have grown from start-up or near start-up stage to companies with market value in excess of $1 billion

Chuck Newhall

Co-Founder & Retired General Partner

Chuck has been at the forefront of innovation in healthcare since co-founding NEA in 1977, with a focus on healthcare services, healthcare information technology and biopharmaceutical investments. His long track record of successful investing includes numerous companies that achieved market capitalizations in excess of $1 billion, and through those investments Chuck has played an integral role in transforming the health care delivery system. He has served as a director of more than 50 venture-backed companies, and currently serves on the boards of Interfusio, Neuropace, Supernus Pharmaceuticals, and Vitae Pharmaceuticals. His prior board memberships include AMERIGROUP, Bravo Health, Caremark, Chomerics, CoGenesys, Comp Health, Genetic Therapy, LifeMetrix, Life Technologies, PatientKeeper, Russ Pharmaceuticals, Senseonics, Scandipharm, Sepracor, Surgical Health, and Zymark Corporation.

In founding NEA, Chuck and his co-founders wanted to build a ‘100-year-firm’—a unique perspective that ultimately enabled NEA to transition, transform and scale as venture capital evolved. Chuck's role in shaping and institutionalizing NEA's collaborative, entrepreneur-focused culture is a key factor in the firm's continued success. In addition to that legacy, Chuck played an integral role in the broader industry's maturation, not only as an investor but as a thought leader and advocate. He founded the Mid-Atlantic Venture Capital Association (MAVA), which now has over 80 venture capital firms that are members, and is one of the most active regional venture associations in the country. He is Chairman Emeritus of MAVA. Chuck continues to be deeply engaged as a venture capital industry advocate and is frequently invited to speak to organizations and institutions about the state of the industry. Recently he worked with Peter Bancroft, a well-known former venture capitalist, the NVCA, and Harvard University to record the oral histories of leading VCs so that the histories of the firms will be not be lost. Sixty interviews have been conducted or scheduled so far. He is a Trustee of the Baltimore Museum of Art and a Member of the University of Maryland, Baltimore County Board of Visitors.

Before co-founding NEA, Chuck was Vice President of T. Rowe Price Associates (Vice President of their New Horizons Fund). He served in Vietnam, commanding an independent platoon including an initial reconnaissance of Hamburger Hill. His decorations include the Silver Star and Bronze Star V (1st OLC.). He received his MBA from the Harvard University Graduate School of Business and his BA in English Literature with honors from the University of Pennsylvania.

Frank Bonsal

Co-founder & Former General Partner

Since retiring from his General Partner role at NEA in 2003, Frank has remained an active angel investor as Founder and Managing Partner of Bonsal Capital, LLC, as Special Partner of New Markets Venture Partners, and as advisor to and Limited Partner in numerous funds in North America, the United Kingdom, and Europe, including Amadeus Capital Partners (UK), Boulder Ventures (MD/CO), Novak Biddle Venture Partners (MD), Sterling Ventures (MD), Trellis Partners (TX), Venturehouse (DC), and Windward Ventures (CA).

Mark Perry

Strategic Advisor & Retired General Partner

Mark joined NEA as a Consultant in 1995 and became a General Partner in 1996. During his eighteen years at NEA Mark focused on information technology investments and served as Head and then Co-head of the NEA Technology team.  He was also Co-head of NEA’s India team and a member of the firm‘s China Investment Committee.   NEA portfolio companies managed by Mark included Growth Networks (acquired by Cisco Systems), iManage (acquired by Interwoven), Magma Design Automation (NASDAQ: LAVA), Silicon Spice (acquired by Broadcom), TiVo (NASDAQ: TIVO) and Trading Dynamics (acquired by Ariba).  Mark retired from NEA at the end of 2012, and remains a Strategic Advisor to the firm.

Mark served as President and Chief Executive Officer and then as Chairman of Viewstar Corporation from April 1994 to December 1995. Before Viewstar, he held several executive positions with Silicon Graphics including: Vice Chairman (1992-1994) responsible for worldwide field operations, Executive Vice President (1988-1991) responsible for the product divisions, and Vice President of Finance and Administration and Chief Financial Officer (1985-1987). Prior to this, Mark was Executive Vice President and Chief Operating Officer of Sonoma Vineyards and a partner at Arthur Young & Company. Mark is a Certified Public Accountant in California. He received a Master’s in Business Administration (with distinction) from the Harvard University Graduate School of Business, and a Bachelor of Arts in Economics (cum laude) from Amherst College.

John Nehra

Retired Special Partner

John joined NEA in 1989 and became a General Partner of NEA in 1993 and became a Special Partner in October 2000. He focuses on a wide range of high-technology companies with an emphasis on healthcare services, information systems and medical devices. Current board memberships include  Cardionomic, CVRx, Davita Healthcare Partners, Denali II Medical, Exploramed III, Ivantis,  Moximed, NeoTract, Prospex Medical III, Rotation Medical,  Van Gogh Imaging and VytronUS. His prior board memberships include among others, Acclarent (acquired by Johnson & Johnson), Apnex Medical, Bridge Medical (acquired by Amerisource Bergen), Celeris Corporation (assets sold), EndoMatrix (acquired by C.R. Bard), Evalve Inc. (acquired by Abbott), Integrated Telecom (acquired by PMC Sierra), IRIDEX Corporation, Minerva Medical, Optical Sensors, Primax Recoveries (acquired by ACS Corp.), Proxima Therapeutics (acquired by CYTEC Corporation) , Surgical Health (acquired by HealthSouth), TargetRx, TELOGY Networks (acquired by Texas Instruments), TransVascular (acquired by Medtronic) Vibrynt, and Vivra (acquired by Gambro ab). Prior to joining NEA in 1989, John was a Managing Director of Alex. Brown & Sons with primary responsibility for developing the firm's healthcare research, investment banking and capital markets businesses. He has also served since 1989 as the Managing General Partner of Catalyst Ventures. John is a Board member of the Baltimore School for the Arts. He received his BA from the University of Michigan.